Letter regarding article by masoudi et al, "National patterns of use and effectiveness of angiotensin-converting enzyme inhibitors in older patients with heart failure and left ventricular systolic dysfunction" - Response

被引：0
|
作者：
Masoudi, FA [1 ]
Havranek, EP
Rathore, SS
Wang, YF
Curtis, JP
Foody, JM
Krumholz, HM
机构：
[1] Denver Hlth Med Ctr, Dept Med, Denver, CO USA
[2] Univ Colorado, Hlth Sci Ctr, Denver, CO USA
[3] Colorado Fdn Med Care, Aurora, CO USA
[4] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA
[5] Yale Univ, Sch Med, Ctr Outcomes Res & Evaluat, Yale New Haven Hosp,Dept Internal Med, New Haven, CT USA
[6] Yale Univ, Sch Med, Ctr Outcomes Res & Evaluat, Yale New Haven Hosp,Dept Epidemiol & Publ Hlth, New Haven, CT USA
来源：
CIRCULATION | 2005年 / 111卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E276 / E277
页数：2
相关论文
共 50 条
  • [31] Underutilization and clinical benefits of angiotensin-converting enzyme inhibitors in patients with asymptomatic left ventricular dysfunction
    Kermani, M
    Dua, A
    Gradman, AH
    AMERICAN JOURNAL OF CARDIOLOGY, 2000, 86 (06): : 644 - 648
  • [32] A meta-analysis of the effect of angiotensin-converting enzyme inhibitors on functional capacity in patients with symptomatic left ventricular systolic dysfunction
    Abdulla, J
    Abildstrom, SZ
    Christensen, E
    Kober, L
    Torp-Pedersen, C
    EUROPEAN JOURNAL OF HEART FAILURE, 2004, 6 (07) : 927 - 935
  • [33] Postoperative treatment with angiotensin-converting enzyme inhibitors in patients with preoperative reduced left ventricular systolic function
    Villacorta, Judith
    Oddoze, Chistiane
    Giorgi, Roch
    Kerbaul, Francois
    Bonnet, Marc
    Collart, Frederic
    Gouin, Francois
    Guidon, Catherine
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2008, 22 (02) : 187 - 191
  • [34] Response by Zhang et al to Letter Regarding Article, "Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19"
    Zhang, Peng
    Zhu, Lihua
    Cai, Jingjing
    Lei, Fang
    Qin, Juan-Juan
    Wang, Yibin
    Yuan, Yufeng
    Rohit, Loomba
    Liu, Peter P.
    Li, Hongliang
    CIRCULATION RESEARCH, 2020, 126 (12) : E142 - E143
  • [35] Response by Cohen et al to Letter Regarding Article, "Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19"
    Cohen, Jordana B.
    Hanff, Thomas C.
    South, Andrew M.
    Sparks, Matthew A.
    Hiremath, Swapnil
    Bress, Adam P.
    Byrd, J. Brian
    Chirinos, Julio A.
    CIRCULATION RESEARCH, 2020, 126 (12) : E140 - E141
  • [36] Angiotensin-converting enzyme inhibitors in patients with coronary artery disease and absence of heart failure or left ventricular systolic dysfunction - An overview of long-term randomized controlled trials
    Danchin, N
    Cucherat, M
    Thuillez, C
    Durand, E
    Kadri, Z
    Steg, PG
    ARCHIVES OF INTERNAL MEDICINE, 2006, 166 (07) : 787 - 796
  • [37] Association Between Mortality and Persistent Use of Beta Blockers and Angiotensin-Converting Enzyme Inhibitors in Patients With Left Ventricular Systolic Dysfunction and Coronary Artery Disease
    LaPointe, Nancy M. Allen
    Zhou, Yi
    Stafford, Judith A.
    Hernandez, Adrian F.
    Kramer, Judith M.
    Anstrom, Kevin J.
    AMERICAN JOURNAL OF CARDIOLOGY, 2009, 103 (11): : 1518 - 1524
  • [38] Survival benefits of angiotensin-converting enzyme inhibitors in older heart failure patients with perceived contraindications
    Ahmed, A
    Kiefe, CI
    Allman, RM
    Sims, RV
    DeLong, JF
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2002, 50 (10) : 1659 - 1666
  • [39] Comparative effectiveness of different angiotensin-converting enzyme inhibitors on the risk of hospitalization in patients with heart failure
    Chitnis, Abhishek S.
    Aparasu, Rajender R.
    Chen, Hua
    Johnson, Michael L.
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2012, 1 (02) : 195 - 206
  • [40] Letter regarding article by Weintraub et al, "Cost-effectiveness of eplerenone compared with placebo in patients with myocardial infarction complicated by left ventricular dysfunction and heart failure"
    Stecker, EC
    McAnulty, JH
    CIRCULATION, 2005, 112 (05) : E74 - E74
12345